Publication | Open Access

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

Hematological MalignancyMedicineAcute Myeloid LeukemiaStem CellsPharmacologyMixed-phenotype Acute LeukemiaPharmacotherapyAdult T-cell Leukemia-lymphomaOncologyCell BiologyCancer ResearchMyeloid Neoplasia